New Vaccine against Malaria
Tuesday, December 19th, 2006
BBC Medical Science –
Researchers are developing a malaria vaccine which blocks development
of the disease-causing parasite while it is still inside the mosquito.
The vaccine targets Pfs25, a protein key to the parasite’s development
during its time in the mosquito’s gut. When a mosquito bites a
vaccinated person it would ingest antibodies which would block the
protein’s action. The US National Institutes of Health study appears in
Proceedings of the National Academy of Sciences. The researchers said
the vaccine had the potential to eliminate malaria from entire
geographic regions. However, experts warned that the vaccine would not
prevent or limit disease in the person who had been vaccinated, and
predicted this could make it difficult to sell the idea to infected
communities. Tests of other malaria vaccines are under way, but as yet
none has been licensed for widespread use. Most attempt to neutralise
the malaria parasite - Plasmodium - while it is in humans. But this has
proved difficult, because Plasmodium cells escape the human immune
system by hiding in liver and blood cells. Malaria kills between one
and three million people worldwide each year, with most of the deaths
in sub-Saharan Africa. More than a million children in Africa die from
malaria each year. The latest vaccine has so far only been tested in
mice. It is a combination of the Pfs25 protein, and other molecules
which are more easily recognised by the immune system, and more likely
to spur it into action. The combination triggers the production of
large quantities of antibodies which, when ingested by the mosquito,
zero in on the malaria parasite in its gut. A microscopic analysis of
the guts of mosquitoes fed a serum containing the antibodies triggered
by vaccination in the mice, showed that they were completely free of
the malaria parasites. In fact, the mice produced higher levels of
antibodies when they were tested three and seven months after their
initial set of jabs, than they did after one week. (12/19/06)
more…


